HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean de Vellis Selected Research

Gliosis

11/2010Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination.
1/2004Prevention of gliotic scar formation by NeuroGel allows partial endogenous repair of transected cat spinal cord.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean de Vellis Research Topics

Disease

4Spinal Cord Injuries (Spinal Cord Injury)
07/2016 - 08/2009
3Inflammation (Inflammations)
01/2014 - 06/2002
3Canavan Disease (Leukodystrophy, Spongiform)
11/2010 - 01/2006
3Nervous System Diseases (Neurological Disorders)
08/2009 - 06/2002
3Alzheimer Disease (Alzheimer's Disease)
08/2009 - 08/2005
3Demyelinating Diseases (Demyelinating Disease)
12/2008 - 06/2002
2Wallerian Degeneration
02/2016 - 06/2005
2Gliosis
11/2010 - 01/2004
2Parkinson Disease (Parkinson's Disease)
08/2009 - 08/2005
2Neurodevelopmental Disorders
02/2007 - 04/2006
2Multiple Sclerosis
08/2005 - 06/2002
2Cicatrix (Scar)
06/2005 - 01/2004
1Infections
11/2011
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2010
1Stroke (Strokes)
08/2009
1Brain Neoplasms (Brain Tumor)
08/2009
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
08/2009
1Huntington Disease (Huntington's Disease)
08/2009
1Amyloid angiopathy
02/2009
1Hyperammonemia
09/2006
1AIDS Dementia Complex
08/2005
1Colonic Neoplasms (Colon Cancer)
12/2002
1Glioma (Gliomas)
12/2002
1Oligodendroglioma
06/2002

Drug/Important Bio-Agent (IBA)

4EnzymesIBA
11/2010 - 01/2006
3aspartoacylaseIBA
11/2010 - 01/2006
2NestinIBA
07/2016 - 02/2016
2Messenger RNA (mRNA)IBA
12/2008 - 12/2002
2CuprizoneIBA
12/2008 - 04/2007
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2008 - 04/2007
2CytokinesIBA
12/2008 - 08/2005
2Proteins (Proteins, Gene)FDA Link
12/2008 - 12/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2008 - 06/2002
2Myelin Basic ProteinIBA
01/2004 - 06/2002
1NAD (NADH)IBA
01/2014
1LigandsIBA
01/2014
12,3-bis(4-hydroxyphenyl)-propionitrileIBA
01/2014
1Estrogen ReceptorsIBA
01/2014
1LipopolysaccharidesIBA
11/2011
1ChromatinIBA
11/2010
1Histones (Histone)IBA
11/2010
1Staphylococcal Protein A (Protein A)IBA
11/2010
1Amyloid beta-PeptidesIBA
02/2009
1MetallothioneinIBA
12/2008
1Glycerol (Glycerine)FDA LinkGeneric
12/2008
1Glutathione (Reduced Glutathione)IBA
12/2008
1Transforming Growth Factor beta (TGF-beta)IBA
12/2008
1Interleukin-10 (Interleukin 10)IBA
12/2008
1AntioxidantsIBA
12/2008
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
12/2008
1Oxidoreductases (Dehydrogenase)IBA
12/2008
1Glutamic Acid (Glutamate)FDA Link
02/2007
1ArginaseIBA
09/2006
1Neurotransmitter Agents (Neurotransmitter)IBA
04/2006
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2005
1Complement System Proteins (Complement)IBA
08/2005
1Peptide Hydrolases (Proteases)FDA Link
08/2005
1PolymersIBA
06/2005
1Glial Fibrillary Acidic ProteinIBA
01/2004
1HydrogelsIBA
01/2004
1PeroxiredoxinsIBA
12/2002
1NF-kappa B (NF-kB)IBA
06/2002
1Lymphotoxin-alpha (Lymphotoxin)IBA
06/2002

Therapy/Procedure

2Therapeutics
08/2009 - 06/2002
1Injections
11/2011
1Intraperitoneal Injections
11/2011
1Radiotherapy
12/2002